Sullivan Christopher Ryan sold AVTX
March 28, 2026 · Form 4 insider transaction
Sullivan Christopher Ryan sold 8,241 shares of Avalo Therapeutics, Inc. at $13.89 per share, a transaction worth $114.5K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
8,241
Price
$13.89
Total value
$114.5K
InsiderSullivan Christopher Ryan
RoleOfficer
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateMarch 28, 2026
Filing dateMarch 31, 2026
Shares owned after33,297
OwnershipDirect
10b5-1 planNo
AmendedNo